Investigation of Novel Immunological Biomarkers by Mass Cytometry in Patients With Early Multiple Sclerosis (CISCO)
CompletedOBSERVATIONAL
Enrollment
90
Participants
Timeline
Start Date
February 19, 2020
Primary Completion Date
March 2, 2022
Study Completion Date
March 2, 2022
Conditions
Multiple Sclerosis
Interventions
OTHER
Biomarkers analysis
Genetic analysis of regions of interest
Trial Locations (1)
Unknown
CHU Rennes, Rennes
All Listed Sponsors
lead
Rennes University Hospital
OTHER
NCT04510350 - Investigation of Novel Immunological Biomarkers by Mass Cytometry in Patients With Early Multiple Sclerosis (CISCO) | Biotech Hunter | Biotech Hunter